Dinsen, S., Baslund, B., Klose, M., Rasmussen, A
Observational studies among patients with type 2 diabetes have shown that the GLP-1 receptor agonist-SGLT-2 inhibitor combination results in more significant improvements in haemoglobin A 1c and blood pressure while lowering body weight than either drug class alone.121314151617 However, these represent surrogate outcomes, and whether this combination is associated with a reduced risk of macrovascular and microvascular complications remains unclear
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis
Takeuchi F, Nishikata N, Nishimura N, Nagao K, Kawamura M
In case of skin contact, rinse with water
Recognizing the confusion these claims have sparked among patients, listeners, and the broader public, Peter uses this episode to provide a framework for thinking critically about complex conditions and the research related to them